Clinical Trial Update: Beta-blocker Administration for Cardiomyocyte Division [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating beta-blocker administration to promote cardiomyocyte division in congenital heart defects, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Double Outlet Right Ventricle
• Tetralogy of Fallot

Drugs mentioned

• Beta-blocker

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Tetralogy of Fallot, Double Outlet Right Ventricle | Phase 1 | Status: RECRUITING